Product Liability Claims in Ireland: The Three Routes, the Three Time Limits, and What Changes on 9 December 2026

What counts as a product liability injury claim in Ireland?

A product liability injury claim arises when a defective product causes physical or psychological harm to you in Ireland. The claim sits within personal injury law, separate from the consumer-rights route for refunds, replacements, or repairs under the Consumer Rights Act 2022 [6]. Here you are claiming compensation for an injury, not contract damages for a faulty good.

Section 1(1) of the Liability for Defective Products Act 1991 [1] defines "damage" to include death, personal injury, and damage to private-use property. Section 3 of the Act sets a small statutory threshold of approximately €441.41, below which property-damage claims are not recoverable. Mental injury is recoverable where a recognised psychiatric condition can be shown. The new 2024 Directive will expressly recognise psychological harm from 9 December 2026 ⁹.

The scenarios that bring a person to this page fall into a handful of cohorts. Most start with an injury from a household product (a kettle, charger, ladder, power tool, or piece of furniture), from a medical implant or device, from a prescription medicine, from contaminated food, or from a vehicle component. Each has its own deep guide further down. The framework on this page applies across all of them.

You do not need to have bought the product yourself. Section 2 of the 1991 Act protects any "injured person", including buyers, gift recipients, family members, workplace users, and bystanders who happened to be near the product when it failed ¹.

The Three-Route Decision Framework

An injured person in Ireland generally has three legal routes to compensation for a product-caused injury, and Section 11 of the 1991 Act preserves all of them ¹. We call this the Three-Route Decision Framework. Pleading in the alternative under more than one route is often the right strategy, particularly when the time limit on one route is closing or the burden of proof on another is heavy.

Route 1: Strict liability under the 1991 Act. The producer is liable on proof of damage, defect, and a causal link between the two. You do not have to prove the producer was negligent. The time limit is 3 years from your date of knowledge, with a 10-year long-stop from when the producer first put the product into circulation (Section 7 ¹).

Route 2: Common-law negligence. You must prove the manufacturer (or any other party in the supply chain) owed a duty of care, breached it, and that the breach caused your injury. The time limit is 2 years from your date of knowledge under the Statute of Limitations (Amendment) Act 1991, Section 2 [2]. Negligence has a longer reach for non-dangerous defects, but the burden of proof is heavier.

Route 3: Medical negligence for hybrid cases. Some product injuries arise inside a clinical encounter where the clinician's care compounds the device or drug defect. A surgeon may have selected the wrong implant, used the right implant negligently, or failed to act on a recall notice. Where clinical breach is genuinely arguable, the claim can run as medical negligence against the hospital or clinician on the standard 2-year limit and outside the IRB.

From handling these matters, the most common mistake an unrepresented claimant makes is choosing one route, usually the 1991 Act because it sounds simpler, and abandoning the others. Section 11 of the 1991 Act expressly preserves your other rights. Where the facts support it, we plead under both the 1991 Act and in negligence in the same Personal Injuries Summons, so neither route is lost on a procedural point.

The three time limits and the 10-year long-stop

Three different limitation periods can apply to a product injury claim in Ireland, and the difference between them can decide whether your claim is preserved or lost. The 1991 Act gives 3 years ¹. Common-law negligence gives 2 years ². The contract route under the Sale of Goods and Supply of Services Act 1980 [5] gives 6 years, though contract recovery for personal injury is rare.

The 1991 Act's 10-year long-stop is the strictest deadline because it can extinguish a claim before the injured person even knew there was a problem. The clock runs from the date the producer first put the product into circulation. For a hip implant placed in 2014, the long-stop is roughly 2024 to 2025 depending on supply-chain dates. For a medicine prescribed in 2018, the long-stop is roughly 2028. As a worked example, PIP breast implants supplied in Ireland between 2001 and 2010 have now passed the 10-year long-stop window under the 1991 Act, so any new claim involving those implants must be brought as common-law negligence rather than strict liability.

The "date of knowledge" rule (Statute of Limitations (Amendment) Act 1991, Section 2 ²) controls when the 2-year and 3-year clocks start. A claimant has knowledge when they knew, or ought reasonably to have known, that they had a significant injury, that the injury was attributable in whole or in part to the act or omission alleged, and that the defendant was identifiable. For 1991 Act claims, the date of knowledge also requires awareness of the producer's identity (Section 7(1) ¹).

A detail that catches many claimants off guard. The 1991 Act's 10-year long-stop runs from when the actual product in question was put into circulation, not from the date the model went on sale. For a defective implant, the relevant date is usually when that specific batch was supplied to the hospital. We assess this at intake because it changes the strategy. If the long-stop has run, the claim becomes negligence-only, and the Bolam-style standard of care is the new central battleground.

Read more on the date-of-knowledge rule for medical negligence if your claim involves clinical care.

Who you can claim against (the Producer Liability Hierarchy)

The 1991 Act sets out a four-step hierarchy of potential defendants, and Section 2(3) provides a fallback that solves the most common problem in product cases, an unidentifiable manufacturer ¹. We call this the Producer Liability Hierarchy. The hierarchy starts with the manufacturer and ends with the supplier who fails to identify someone higher up the chain.

Section 8 of the 1991 Act makes co-defendants jointly and severally liable as concurrent wrongdoers under Part III of the Civil Liability Act 1961 [4]. In practice that means if you can identify any one of the producer, importer, or supplier chain, you can recover the full award from that party. They then pursue the others between themselves.

For workplace injuries from a defective tool, the employer often sits alongside the producer in negligence under the Safety, Health and Welfare at Work Act 2005 [7]. See defective workplace equipment for the employer-liability layer that runs in parallel.

Does your claim go through the Injuries Resolution Board?

Most product liability injury claims in Ireland start at the Injuries Resolution Board (IRB) before any court proceedings, but medical negligence claims are statutorily exempt under Section 3 of the Personal Injuries Assessment Board Act 2003 [3]. The routing decision turns on which of the three legal routes you are pleading.

According to the IRB Annual Report 2024 [10], the Board handled 20,837 claims in 2024 and made €168 million in awards, with 70 per cent of respondents consenting to assessment and 50 per cent of assessments accepted by both parties. The average resolution time through the IRB is just over two years against almost six years through litigation, and average legal fees are €597 through the IRB against €24,786 through litigation ¹⁰. The figures are corroborated in coverage by RTÉ News (9 July 2025) and Irish Legal News (9 July 2025). For most pure product injury claims, the IRB is the procedural gateway.

Hybrid claims, where the injury arose partly from a defective device and partly from clinical care, sit in a routing grey zone. Misclassification has real consequences. A claim filed entirely as medical negligence may face an objection from the device manufacturer that the IRB application should have been made first. The reverse also happens. We assess routing at the first consultation because it determines the procedural timeline and the order in which you must serve evidence.

Routing breaks down as follows. Pure product liability claims, including consumer goods, contaminated food, and vehicle components, must go through the IRB. Medical negligence claims involving only clinical breach are exempt under Section 3 of the PIAB Act 2003 ³ and proceed straight to court. Hybrid claims involving both a defective device and a clinical breach are decided case by case, with strategic pleading required. Workplace injuries from defective equipment go through the IRB on the employer-liability side, with the manufacturer often joined later in the proceedings.

The next step is to confirm which of the Three-Route Decision Framework branches fits your facts. For broader IRB context see the public liability claims hub, where the same IRB process applies to slip-and-fall and premises injuries.

What you have to prove and the defences against you

Under the 1991 Act the claimant proves three things, namely damage, defect, and a causal link between the two (Section 4 ¹). Negligence is not part of the case. A product is "defective" if it fails to provide the safety a person is entitled to expect taking all circumstances into account, including its presentation, its expected use, and the time it was put into circulation (Section 5 ¹).

The producer has six defences under Section 6 ¹:

1. The producer did not put the product into circulation.
2. The defect arose after the product was put into circulation.
3. The product was not made for an economic purpose.
4. The defect was caused by compliance with a mandatory legal requirement.
5. The state of scientific and technical knowledge at the time was such that the defect could not be discovered (the "development risks" defence).
6. A component-maker is not liable where the defect lay in the design of the final product into which the component was fitted.

The development-risks defence sounds powerful but is rebuttable. What the official guidance does not cover is that the defence is undermined where post-market surveillance data, regulatory safety signals, or contemporaneous scientific literature shows the manufacturer should have known. Where the product belongs to the same production batch as a known-defective batch, particularly for high-risk medical devices, the Court of Justice of the European Union has held that the product can be classified as defective without identifying the specific defect in the implanted unit.

Two practical defences come up often. The first is misuse, using the product in a way the manufacturer did not foresee. The second is contributory negligence under the Civil Liability Act 1961 ⁴, using the product in a way that ignored an obvious risk. Recent Court of Appeal coverage shows both defences succeeding where the claimant ignored ordinary precautions. Pouring boiling water into an unmarked glass jug was treated as misuse and contributory negligence in one decision, and a commercial gas oven where the control knobs allegedly melted was held to have been used outside its design parameters in another.

The takeaway from the case law is that strict liability removes the negligence question, although it does not remove the burden of proving the product was defective and used as intended. Preserving the product, the packaging, and the receipt is the single most important step.

Compensation under the 2021 Personal Injuries Guidelines

Compensation in Irish product liability claims is assessed under the Personal Injuries Guidelines (April 2021) [13], which replaced the former Book of Quantum. The Guidelines apply both in court and at the IRB and set graduated brackets for general damages (pain and suffering) by injury type and severity. Special damages such as medical bills, lost earnings, and future care are assessed separately and depend on documented financial loss.

According to the IRB Personal Injuries Award Values Report (April 2025, covering 2024) [11], the average IRB assessment for full-year 2024 was €18,967 and the median was €13,000, both stable across both halves of the year. Roughly 59 per cent of awards fell under €15,000, and 7 per cent reached €50,000 or more. The cap for the most catastrophic injuries under the current Guidelines is €550,000 in general damages ¹³. These figures cover all claim categories, including motor, employer, public, and product, and a serious product injury can reach the upper end of the catalogue.

One detail that the Guidelines summary does not always make obvious is that the Guidelines deal only with general damages. Special damages can substantially exceed the general-damages bracket, particularly where revision surgery, ongoing therapy, or future loss of earnings are in play. The IRB H1 2024 report records a special-damages award exceeding €360,000 in a single case ¹⁰. We see the same in product cases involving long-term consequences from medical implants or chronic conditions caused by pharmaceutical exposures.

The Judicial Council submitted draft revised Guidelines on 4 February 2025 proposing a 16.7 per cent uplift across most brackets ¹³. On 9 July 2025 the Cabinet Sub-Group on Insurance Reform announced that the Minister for Justice would not bring a resolution seeking Oireachtas approval at that point and that the matter is under further review. The April 2021 Guidelines remain the operative figures for any claim assessed today. For deeper compensation context see compensation under the Personal Injuries Guidelines.

One counter-intuitive observation from product liability practice in Ireland. Simple consumer-product claims under the 1991 Act often settle faster than road traffic claims, because liability is strict and defendants frequently prefer early resolution to fighting defect arguments in court. The bottleneck in product cases is usually causation, not negligence, which makes a well-preserved product and a clean medical record the determining factors in pace of settlement.

What changes on 9 December 2026

From 9 December 2026, Directive (EU) 2024/2853 [9] replaces the 1985 Directive that the 1991 Act transposed, and the new regime applies to products placed on the EU market or put into service after that date. Products placed before 9 December 2026 continue to be governed by the 1991 Act for the rest of their commercial life, including the 10-year long-stop. Ireland's Department of Enterprise, Trade and Employment confirmed in its June 2025 transposition timetable that the deadline is expected to be met.

The new Directive widens the regime in five practical ways. The definition of "product" expands to include software, AI systems, and digital manufacturing files. The list of liable parties broadens beyond the producer to include "economic operators", such as fulfilment service providers and online platforms that can be pursued where the manufacturer cannot. Medically recognised psychological harm is expressly compensable as personal injury. The previous property-damage threshold is removed. The long-stop for latent personal injuries (where symptoms manifest slowly) extends from 10 years to 25 years.

What this means in practice in 2026. A hip implant placed in 2025 will spend its commercial life under the 1991 Act regime. A pacemaker placed in 2027 will be governed by the new Directive, including the 25-year long-stop. The transition window is binary, not gradual. We are already factoring the regime split into our intake assessments because it changes the limitation calculation and the available defendants.

As of 7 May 2026, Ireland has not yet published the Statutory Instrument transposing Directive 2024/2853 into domestic law. The transposition deadline remains 9 December 2026. The official channels to watch for the transposing instrument are Iris Oifigíuil and the Department of Enterprise, Trade and Employment website. We update this page as the instrument is laid before the Oireachtas.

Find the deep guide for your situation

This page covers the framework that applies across all product-injury claims. Each cohort below has its own deep guide with the specific evidence, defendants, and case patterns relevant to that product type.

If your injury arose during cosmetic surgery rather than from the implant itself, see cosmetic surgery negligence. For a prescription error rather than a defective drug, see medication errors.

What to do in the first 48 hours

The first 48 hours after a product injury determine more than people realise about how the claim runs. Evidence that sits in plain sight on day one is hard to recover on day twenty.

From handling these claims, the single biggest reason cases are weakened or lost is failing to preserve the actual product within the first 48 hours. Once the kettle goes back to the manufacturer, or the failed component is binned by the garage, the strict-liability claim is harder to run because the defect itself can no longer be examined.

Why product liability claims fail (in our experience)

Five recurring reasons defeat or weaken product liability claims in Ireland. The order below reflects how often we see each one cause real damage to a viable case.

1. Lost product. The single most damaging mistake. The kettle goes back to the retailer for a refund, the hospital throws out the explanted device, or the garage scraps the failed brake disc. Without the product itself, the strict-liability route under the 1991 Act becomes much harder because the defect cannot be examined by an engineer or expert.
2. Missed long-stop. A claimant discovers an implant problem 11 years after surgery and finds the 10-year long-stop in Section 7(2) has already run. Common-law negligence remains, but the burden of proof shifts to showing breach of duty rather than defect.
3. Wrong route chosen. A pure-product claim filed as medical negligence faces an objection from the manufacturer that the IRB application should have been made first. The reverse mistake, pleading clinical breach as a 1991 Act claim, also adds delay and costs.
4. Retailer-substitution mistake. The claimant accepts the retailer's offer to "deal with it directly with the manufacturer", waits, and then receives only a refund letter. Once a substitute product or a refund is accepted as full settlement, the original injury claim becomes harder to sustain.
5. Date of knowledge fixed too late. Filing on the assumption that "knowledge" begins at formal medical diagnosis can blow the limitation period if a court finds the claimant should have known earlier from prior symptoms or a public recall notice.

Each of these failure modes is preventable with early advice. The Three-Route Decision Framework choice and Producer Liability Hierarchy mapping at intake usually catch the first three. Disciplined evidence preservation catches the fourth. A solicitor's date-of-knowledge analysis catches the fifth.

Decision factors and how to act

At this point, you'll need to decide whether to act on your own or get a solicitor's view. The factors below usually push the decision one way or the other.

Quick answers (voice-friendly)

What if your situation does not fit the standard pattern?

The framework above answers the standard route, time, and defendant questions. The next step is to look at the edge cases that come up most often. The questions below address the situations where the standard pattern needs adjusting.

Common questions

What to consider next

Can I claim if a recall was issued for the product? Yes. A recall is useful evidence that a defect existed and that the producer knew. It does not by itself prove your specific unit was defective, but it shifts the practical burden in your favour. This leads to the question of whether to file before or after the recall investigation concludes, which depends on the limitation calendar.

What if I was injured by a product abroad? Cross-border product claims involve Rome II and the place where the damage manifested. Ireland often has jurisdiction where the injury occurred or manifested here, even if the product was bought elsewhere. The Three-Route Decision Framework still applies, but conflict-of-laws rules can change which substantive law governs.

Can a group claim be brought collectively? The Representative Actions for the Protection of the Collective Interests of Consumers Act 2023 [8] commenced 30 April 2024 and allows a designated Qualified Entity to bring a representative action for breaches of consumer-protection law including product safety. Individual claims for personal injury still proceed separately.

What if the product caused a death? A fatal-injury claim is brought by the dependants of the deceased under Part IV of the Civil Liability Act 1961 ⁴. The claim covers loss of dependency, mental distress (statutory cap), and funeral costs. The 1991 Act expressly includes death as compensable damage under Section 1(1). The 3-year and 10-year clocks still apply, with the date of knowledge running from the date of the dependant's awareness of the connection between the death and the defect.

Can my spouse or family claim alongside me? Yes in some circumstances. A spouse or close family member may have a separate claim for nervous shock if they witnessed the injury or its immediate aftermath, subject to the conditions in Kelly v Hennessy and the cases that followed. They may also claim consortium in limited circumstances. These secondary claims run on the same 2-year tort limitation, not the 3-year 1991 Act period.

What does my own insurance cover? Household contents insurance rarely covers personal injury caused by a defective product to the policyholder. Some travel-insurance policies cover product-related injuries abroad. Check the policy's "personal liability" and "personal accident" sections carefully. None of these displace the 1991 Act route against the producer.